- Robert Jack
- January 8, 2026
Cybersecurity and PHI Exposure: The New Board-Level M&A Risk in Healthcare
Cybersecurity and PHI Exposure: The New Board-Level M&A Risk in Healthcare Key Takeaways Introduction Healthcare mergers and acquisitions are no longer judged solely on revenue, patient volume, or EBITDA multiples. In today’s environment, cybersecurity posture and PHI exposure have become decisive factors in whether a deal closes, how it is priced, and who ultimately bears […]
Read MoreRecent Posts
- Price vs Certainty: What Healthcare Owners Should Really Optimize For
- What Gets Shared, When: How Healthcare M&A Agencies Control Information to Accelerate Deals
- The CEO Buffer: How Agencies Absorb Buyer Pressure During a Sale Process
- The Presentation Gap: Why strong healthcare businesses can still look weak to buyers
- What Institutional Buyers Expect Before Pursuing a Larger Healthcare Transaction
Recent Comments
Latest Post
Tags
dental practice M&A dental practice sale due diligence exit planning healthcare acquisitions healthcare business broker healthcare business brokers healthcare business sale healthcare business valuation healthcare consolidation healthcare deal preparation healthcare deal structuring healthcare due diligence healthcare exit planning healthcare exit strategy healthcare investment healthcare M&A healthcare m&a advisors healthcare M&A advisory healthcare M&A agency healthcare m&a broker healthcare M&A firm healthcare M&A firms healthcare mergers healthcare mergers and acquisitions healthcare practice sale healthcare private equity healthcare transaction advisory healthcare transactions healthcare valuation m&a healthcare advisors MedBridge Capital medical practice sale medical practice valuation MedSpa business brokers medspa M&A medspa valuation operational efficiency practice valuation private equity healthcare private equity healthcare deals private equity MedSpa quality of earnings selling a medical practice sell medical practice